INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Novel predictors of mild paravalvular aortic regurgitation in SAPIEN 3 transcatheter aortic valve implantation

EuroIntervention 2018;14:58-68 published online February 2018. DOI: 10.4244/EIJ-D-18-00005

Gilbert H.L. Tang1*, MD, MSc, MBA; Syed Zaid2, MD; Samuel R. Schnittman3, BA; Hasan Ahmad4, MD; Ryan Kaple5, MD; Cenap Undemir6, MD; Tanya Dutta4, MD; Angelica Poniros4, RCS; Joanne Bennett6, FNP-BC; Cheng Feng7, DO; Martin Cohen4, MD; Steven L. Lansman6, MD, PhD

1. Department of Cardiovascular Surgery, Mount Sinai Health System, New York, NY, USA; 2. Department of Medicine, Westchester Medical Center, Valhalla, NY, USA; 3. Icahn School of Medicine at Mount Sinai, New York, NY, USA; 4. Division of Cardiology, West

Aims: Paravalvular leak (PVL) remains an important issue in TAVI. The Edwards SAPIEN 3 (S3) valve has reduced PVL but in up to one third of patients mild leak remains. Our study aimed to

Forgot your password?

No account yet? Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

aortic stenosisparavalvular leaktavi

Interventions for valvular diseaseTAVI

Share on Facebook Share on Twitter Share on Linkedin